Physician profile
Christian Spies
NPI 1184816316
$718,809.02
in general payments reported to CMS, 2019-2025
20 companies · $129K in 2025
The $129K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185K · 2020: $74K · 2021: $100K · 2022: $114K · 2023: $77K · 2024: $41K · 2025: $129K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $119K · Consulting Fee: $62K · Travel and Lodging: $54K · Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $119,281.25 |
| Consulting Fee | $61,875.00 |
| Travel and Lodging | $54,227.59 |
| Food and Beverage | $10,513.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $369,412.54 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Medtronic, INC. | $167,783.23 | 2021-2025 | Corevalve Evolut R, Harmony, Symplicity G3 |
| Medtronic Vascular, INC. | $142,857.16 | 2019-2020 | |
| Jenavalve Technology, INC. | $17,984.93 | 2019-2022 | |
| Abbott Laboratories | $11,513.60 | 2019-2025 | Mitraclip, Amplatzer Amulet, Triclip |
| Biotronik INC. | $2,483.53 | 2019-2025 | Selectra, Amvia Edge, Acticor 7 Vr-T Dx |
| Boston Scientific Corporation | $1,834.67 | 2019-2025 | Watchman Flx, Farapulse, Watchman |
| Shockwave Medical, INC | $1,718.06 | 2019-2022 | |
| Philips North America LLC | $1,583.06 | 2023 | |
| Acist Medical Systems, INC. | $663.42 | 2019-2025 | |
| Atricure, INC. | $419.95 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Abiomed | $169.24 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $97.89 | 2019 | |
| Heartflow, INC. | $55.27 | 2019 | |
| Bard Peripheral Vascular, INC. | $52.51 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $48.40 | 2022 | |
| Angiodynamics, INC. | $45.49 | 2019 | |
| Cathworks, INC. | $37.37 | 2020 | |
| Janssen Pharmaceuticals, INC | $31.43 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christian Spies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.